Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More News and Success Stories.
-
22 Jul 2026
See more Taiwanese company TCI invests €20 million in Barcelona to establish its first European production and R&D centerTaiwanese company TCI invests €20 million in Barcelona to establish its first European production and R&D center
-
17 Jul 2026
See more German multinational Fischer chooses Catalonia for its first automated warehouse outside GermanyGerman multinational Fischer chooses Catalonia for its first automated warehouse outside Germany
-
13 Jul 2026
See more Submer to invest over €1 billion in AI data center in CataloniaSubmer to invest over €1 billion in AI data center in Catalonia
-
29 Jun 2026
See more Barcelona–Shanghai Green Corridor strengthens Catalonia's business ties with ChinaBarcelona–Shanghai Green Corridor strengthens Catalonia's business ties with China
